Multiple septic complications of disseminated candidiasis following anorectal sepsis in a non-immunocompromised patient.
Salemis
Nikolaos S
NS
Tsolakis
Konstantinos
K
Aloizos
Stavros
S
Tsohataridis
Efstathios
E
D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000627:therapeutic use; D001004:Anus Diseases / Q000150:complications* / Q000382:microbiology; D002176:Candida albicans / Q000187:drug effects / Q000302:isolation & purification* / Q000472:pathogenicity; D002177:Candidiasis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D004823:Epididymitis / Q000188:drug therapy / Q000382:microbiology; D015725:Fluconazole / Q000627:therapeutic use; D016469:Fungemia / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D007121:Immunocompetence; D008168:Lung / Q000382:microbiology / Q000473:pathology; D008172:Lung Diseases, Fungal / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D008297:Male; D009920:Orchitis / Q000188:drug therapy / Q000382:microbiology; D012002:Rectal Diseases / Q000150:complications* / Q000382:microbiology; D018805:Sepsis / Q000150:complications* / Q000382:microbiology; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000382:microbiology
D000935:Antifungal Agents; D015725:Fluconazole